Abstract
Renal cell carcinoma (RCC) is a life threatening disease, the most lethal among urinary tract tumors. It accounts for about 2-3% of adult solid malignancies, with a reported worldwide annual increase of 1.5-5.5%. Surgical intervention is the primary treatment for early-stage RCC, however nephrectomy alone offers limited benefit in patients with metastatic disease, except for palliative reasons. The aim of this review is to study the role of surgical intervention in the treatment algorithm of metastatic renal cell carcinoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
